Nuheara (ASX:NUH) receives US FDA registration for a new hearing aid

09MarMarch 9, 2021

Nuheara (ASX:NUH) receives US FDA registration for a new hearing aid

Nuheara (ASX:NUH) has received US Food and Drug Administration establishment registration for a medical device listing of a new hearing aid, IQbuds² PRO.

The PRO, alongside IQbuds² MAX will be the second product to be derived from the recently developed IQbuds² hardware platform.

It has been designed to provide deeper levels of hearing technology sophistication, while delivering higher levels of hearing enhancement and amplification.

The PRO is expected to be launched in the US later in the calendar year.

Shares in Nuheara (ASX:NUH) are trading 4.55 per cent higher at 5 cents.

Copyright 2021 – Finance News Network

Source: Finance News Network

13DecDecember 13, 2019

Graham Smith retires from Xero (ASX:XRO) board

13 Dec 2019 - Cloud-based admin helper Xero (ASX:XRO) announced today that Graham Smith will retire from the board, stepping down as chair.

04DecDecember 4, 2020

Beacon Lighting (ASX:BLX) launches property fund

04 Dec 2020 - Beacon Lighting Group (ASX:BLX) has established a property fund and acquired its first property. The Beacon Commercial Property Fund has been established to own several subfunds which will be used to acquire properties for the purposes of leasing them to Beacon Lighting and other tenants.

19SepSeptember 19, 2019

AVITA Medical study shows RECELL helps acne scars

19 Sep 2019 - Regenerative medicine company AVITA Medical (ASX:AVH) has had a study into treating acne scars published in Aesthetic Plastic Surgery by the Department of Plastic Surgery at Peking Union Medical College Hospital exploring the use of the RECELL.